Results 51 to 60 of about 98,103 (155)

Complexed rifampicin with iron mitigates doxorubicin-induced nephrotoxicity. [PDF]

BMC Pharmacol Toxicol
Basal OA, Saad EA, El Sadda RR.
europepmc   +1 more source

Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease. [PDF]

J Antimicrob Chemother
Rodgers MP, Stemkens R, Dahl VN, van Laarhoven A, Hoefsloot W, Lemson A, van Ingen J, Aarnoutse RE.   +7 more
europepmc   +1 more source

Mavacamten toxicity, hepatic dysfunction, and rifampicin: cause or coincidence? [PDF]

Eur Heart J Case Rep
Mapelli M, Costantino S, Maragna R.
europepmc   +1 more source

Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model. [PDF]

PLoS One
Rusnak J, Delcheva V, Theile D, Blank A, Frey N, Preusch MR.   +5 more
europepmc   +1 more source

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates

Frontiers in Microbiology, 2017
Sandeep Sharma, Sandeep Sharma, Noton K. Dutta   +2 more
doaj   +1 more source

Rifampicin induced purpura of left lower limb: Illustrative medical image. [PDF]

IDCases
Jain A, Toshniwal A.
europepmc   +1 more source

Mucoadhesive Chitosan-Gellan Gum Nanoparticles for Rifampicin Delivery: Taguchi Optimization and In Vitro Release Behavior. [PDF]

Pharmaceutics
Cheung SY, Galiyeva A, Tazhbayev Y, Zhumagaliyeva T, Bardadym Y, Aseyev V.   +5 more
europepmc   +1 more source

Efficacy and safety of daily drug regimens containing high-dose versus standard-dose rifampicin for treating pulmonary tuberculosis: Systematic review and meta-analysis. [PDF]

Lung India
Aggarwal AN, Agarwal R, Dhooria S, Bhavani PK, Prasad KT, Sehgal IS, Muthu V.   +6 more
europepmc   +1 more source

Beyond Inhibition: Sublethal Rifampicin-Induced Molecular Adaptations Confer Phenotypic Drug Tolerance in Mycobacteria. [PDF]

ACS Infect Dis
Stuart BD, van der Merwe A, Chengalroyen MD, Moosa A, Warner DF, Blackburn JM, Ganief TA.   +6 more
europepmc   +1 more source

Uncovering resistance pathways to first- and last-line antibiotics in <i>Mycobacterium tuberculosis</i> populations. [PDF]

Microb Genom
Srilohasin P, Williams JM, Tay AP, Gillieatt BF, Pascoe DR, Maharjan RP, Chaipraset A, Ajawatanawong P, Cain AK.   +8 more
europepmc   +1 more source